Altre lingue Cytek Biosciences, Inc.

Azioni

CTKB

US23285D1090

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
5,96 ^USD	+0,68%		-5,40%	-34,65%

20/03	L'insider di Cytek Biosciences ha venduto azioni per un valore di 269.600 dollari, secondo un recente documento della SEC	MT
19/03	Cytek Biosciences nomina William McCombe come CFO e riafferma la guidance per il 2024	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing	20/03
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance	19/03
Cytek® Biosciences Names William McCombe Chief Financial Officer	19/03
Cytek® Biosciences Names William McCombe Chief Financial Officer	19/03
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics	19/03
Cytek Biosciences, Inc. Announces CFO Changes	19/03
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China	08/03
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions	07/03
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions	07/03
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China	07/03
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on May 19, 2023.	01/03
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024	01/03
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook	28/02
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Cytek Biosciences to Participate in Upcoming Investor Conferences	07/02
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	07/02
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University	18/01
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries	17/01
Cytek Biosciences, Inc. Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries	17/01
Cytek Seeks Merger and Acquisitions	11/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cytek Biosciences, Inc.

Azioni

CTKB

US23285D1090

Altre lingue

Filtri